Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-470

  1. 2,282 Posts.
    lightbulb Created with Sketch. 1205
    He (or rather MSB has - or rather Oaktree has - but essentially for the time being he has) a patent - Mesenchymal Stem Cells expressing TNF-alpha receptors.

    He doesn't really have secrets from folk like me that can read the patents and the science papers he is really only keeping the non sciencey types in the dark - (the ignorant are trading with the ignorant why does that matter because its the non sciency types (which vastly outnumber the sciency types - in terms of voting and in terms of money behind shares) that set the management (kpis or no kpis) that sets that rate of progress.

    Stupid in large amounts ends up hurting stupid and not stupid alike by reducing the rate of progress to a snails crawl.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.66
Change
0.010(0.61%)
Mkt cap ! $2.114B
Open High Low Value Volume
$1.66 $1.69 $1.64 $5.790M 3.482M

Buyers (Bids)

No. Vol. Price($)
1 460 $1.66
 

Sellers (Offers)

Price($) Vol. No.
$1.66 67181 6
View Market Depth
Last trade - 16.10pm 11/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.